Tumor genetic testing for patient selection in phase I clinical trials: the case of PI3K inhibitors. (Q53963513)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tumor genetic testing for patient selection in phase I clinical trials: the case of PI3K inhibitors. |
scientific article |
Statements
1 reference
Tumor genetic testing for patient selection in phase I clinical trials: the case of PI3K inhibitors. (English)
1 reference
Dejan Juric
1 reference
José Baselga
1 reference
23 January 2012
1 reference
30
1 reference
8
1 reference
765-766
1 reference
Identifiers
1 reference